We are currently sold out across our full range. Be the first to know when stock returns. Register your interest
For research use only - NOT for human consumptionNext-day tracked deliveryDiscreet plain packaging≥99% purity, HPLC verified

RT-GLP1 UK

RT-GLP1 (triple receptor agonist, often shortened to "reta") is supplied by Onyx Peptides as a high-purity research material for laboratory use, with tracked, discreet UK dispatch.

Research use only. Everything on this page is supplied strictly as a research material for in-vitro laboratory use. It is not a medicine, has not been assessed by the MHRA for human use, and is not for human or veterinary use. Nothing here is medical advice.

What is RT-GLP1?

RT-GLP1 is an investigational peptide developed by Eli Lilly. It is a single molecule that acts on three hormone receptors at once: GLP-1, GIP and glucagon. That is why it is usually described as a triple agonist, and why it is compared with the dual agonist tirzepatide and the single agonist semaglutide.

How RT-GLP1 is studied

RT-GLP1 has been studied in Phase 2 clinical research published in the New England Journal of Medicine in 2023, and is being evaluated in Lilly's Phase 3 TRIUMPH programme. In the laboratory it is used to study how the three receptor pathways interact in energy metabolism.

  • GLP-1, GIP and glucagon receptor pharmacology
  • Energy balance and metabolic signalling
  • Comparisons between single, dual and triple agonists

RT-GLP1 from Onyx Peptides

We supply RT-GLP1 as lyophilised vials in 10, 15, 20 and 30 mg, and as ready-prepared pre-filled pens in 10, 20, 30 and 40 mg. Every batch is independently tested by HPLC to ≥99% purity before it is listed, and carries a batch number that links to its certificate of analysis.

FormatStrengthPricePrice per mg
Pre-filled pen10 mg£110.00 £79.00£7.90
Pre-filled pen20 mg£125.00 £89.00£4.45
Pre-filled pen30 mg£145.00 £99.00£3.30
Pre-filled pen40 mg£160.00 £109.00£2.73
Vial10 mg£55.00 £48.99£4.90
Vial15 mg£65.00 £57.99£3.87
Vial20 mg£75.00 £65.00£3.25
Vial30 mg£95.00 £75.00£2.50

Prices update automatically from the shop. Research use only.

Storage and delivery

Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light.

Orders are dispatched from the UK by tracked delivery in plain, discreet black padded packaging, with no product names on the outside. See shipping & delivery.

Frequently asked questions

What is RT-GLP1?

RT-GLP1 is an investigational peptide developed by Eli Lilly.

Is RT-GLP1 a licensed medicine in the UK?

RT-GLP1 is not a licensed medicine in the UK or anywhere else. It is still in clinical development. Onyx Peptides supplies it only as a research material for in-vitro laboratory use.

How is RT-GLP1 supplied?

Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light. Each batch is HPLC-tested to at least 99% purity.

How is my order packaged?

In plain, discreet black padded packaging with no product names on the outside, sent by tracked UK delivery.

Further reading

RT-GLP1: the triple-agonist peptide explained

Related

What is RT-GLP1?

Scroll to Top